For example, in the Slovak Republic and Spain, patients need to pay certain innovative pharmaceuticals which are provided free in the other countries. In Canada, patients are required to pay for the pharmaceuticals used for treating diseases/conditions other than cancer (for cancer patients below age 65), those used outside of hospitals in Denmark and Sweden, and those used in the private sector in Portugal. In Denmark and Sweden, there are also maximum payment limits (in the former, for chronically ill patients with permanent or high use of pharmaceuticals), beyond which pharmaceuticals are provided for free.